Blood trauma testing for mechanical circulatory support devices

Biomedical Instrumentation and Technology

Volumn 45, Issue 4, 2011, Pages 334-339

  Giridharan, Guruprasad A ^a   Sobieski, Michael A ^b   Ising, Mickey ^b   Slaughter, Mark S ^b   Koenig, Steven C ^b  

^a University of Louisville   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN SOCIETY FOR TESTING AND MATERIALS; ASTM GUIDELINES; BLOOD SAMPLES; BOVINE BLOOD; CLINICAL OUTCOME; DIFFERENTIAL PRESSURES; EXPERIMENTAL PROCEDURE; FLOW LOOPS; FOOD AND DRUG ADMINISTRATION; MECHANICAL CIRCULATORY SUPPORT DEVICE; STUDY DESIGN; TESTING PROCEDURE; TESTING PROTOCOLS;

BLOOD; EQUIPMENT; SAFETY TESTING; STANDARDIZATION;

MATERIALS TESTING;

HEMOGLOBIN; HEPARIN;

ASSISTED CIRCULATION; BLOOD CELL COUNT; BLOOD DONOR; BLOOD SAMPLING; CANNULA; CONTROLLED STUDY; COW; DEVICE SAFETY; FOOD AND DRUG ADMINISTRATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; NONHUMAN; REVIEW; STANDARDIZATION; TEMPERATURE;

ADULT; ANIMALS; BLOOD CHEMICAL ANALYSIS; CATTLE; CHILD; EQUIPMENT FAILURE ANALYSIS; EQUIPMENT SAFETY; GUIDELINE ADHERENCE; HEART-ASSIST DEVICES; HEMOLYSIS; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 80051575490     PISSN: 08998205     EISSN: None     Source Type: Journal    
DOI: 10.2345/0899-8205-45.4.334     Document Type: Review

References (25)

1. Kameneva MV, et al. Effects of Turbulent Stresses Upon Mechanical Hemolysis: Experimental and Computational Analysis. ASAIO Journal. 2004;50(5):418.
2. Yasuda T, et al. Influence of Static Pressure and Shear Rate on Hemolysis of Red Blood Cells. ASAIO Journal. 2001;47(4):351.
3. ASTM, ASTM F1841-97: Standard Practice for Assessment of Hemolysis in Continuous Flow Blood Pumps. 2005.
4. ASTM, ASTM F1830-97: Standard Practice for Selection of Blood for In Vitro Evaluation of Blood Pumps. 2005.
5. FDA. Research Project: Evaluation of Blood Damage Caused by Medical Materials and Devices. Available at: www.fda.gov/MedicalDevices/ ScienceandResearch/ucm208183.htm. Accessed May 4, 2011.
6. FDA. Guidance for Industry and FDA Staff: General Considerations for Animal Studies for Cardiovascular Devices. July 29, 2010.
7. Naito K, et al. Comparative Hemolysis Study of Clinically Available Centrifugal Pumps. Artif Organs. 1996;20(6):560-3. (Pubitemid 26246662)
8. Qian KX. Experience in Reducing the Hemolysis of an Impeller Assist Heart. ASAIO Trans. 1989;35(1):46-53.
9. Tayama E, et al. The Hemolysis Test of the Gyro C1E3 Pump in Pulsatile Mode. Artif Organs. 1997;21(7):675-9. (Pubitemid 27314406)
10. Zhang J, et al. Computational and Experimental Evaluation of the Fluid Dynamics and Hemocompatibility of the CentriMag Blood Pump. Artif Organs. 2006;30(3):168-77.
11. Naito K, Mizuguchi K, and Nose Y. The Need for Standardizing the Index of Hemolysis. Artif Organs. 1994;18(1):7-10. (Pubitemid 24053456)
12. Kennington JR, et al. Numerical Modeling of a Novel Viscous Impeller Pump for Cavopulmonary Assist of Fontan Physiology. (In review).
13. Giridharan G, et al. Performance Evaluation of a Pediatric Viscous Impeller Pump for Fontan Cavopulmonary Assist. (In Review).
14. Rodefeld MD, Coats B, Fisher T, Giridharan GA, Chen J, Brown JW, Frankel SH. Cavopulmonary Assist for the Univentricular Fontan Circulation: Von Karman Viscous Impeller Pump. J Thorac Cardiovasc Surg. 2010;140(3):529-36.
15. Wurzinger L, Opitz R, and Eckstein H. Mechanical Blood Trauma: An Overview. Angiology. 1986;38:81-97.
16. Giersiepen, M, et al. Estimation of Shear Stress-Related Blood Damage in Heart Valve Prostheses - In Vitro Comparison of 25 Aortic Valves. Int J Artif Organs. 1990;13(5):300-6. (Pubitemid 20310869)
17. Kormos, RL, et al. Rheologic Abnormalities in Patients With the Jarvik-7 Total Artificial Heart. ASAIO Trans. 1987;33(3):413-7.
18. Hung, TC, et al. Effects of Long-Term Novacor Artificial Heart Support on Blood Rheology. ASAIO Trans. 1991;37(3):M312-3.
19. Kameneva MV, et al. Effects of Turbulent Stresses Upon Mechanical Hemolysis: Experimental and Computational Analysis. ASAIO Journal. 2004;50(5):418-423. (Pubitemid 39237949)
20. Androne, AS, et al. Hemodilution Is Common in Patients With Advanced Heart Failure. Circulation. 2003;107(2):226-229.
21. Malehsa, D, Meyer AL, Bara C, Struber M. Acquired von Willebrand Syndrome After Exchange of the HeartMate XVE to the HeartMate II Ventricular Assist Device. Eur J Cardiothorac Surg. 2009;35(6):1091-1093.
22. Schuster M, Kocher A, John R, Hoffman M, Ankersmit J, Lietz K, Edwards N, Oz M, Itescu S. B-Cell Activation and Allosensitization After Left Ventricular Assist Device Implantation Is Due to T-Cell Activation and CD40 Ligand Expression. Human Immunology. 2002;63(3):211-220. (Pubitemid 34246054)
23. Dewald O, et al. Platelet Activation Markers in Patients With Heart Assist Device. Artif Organs. 2005;29(4):292-299. (Pubitemid 41632987)
24. Klovaite J, et al. Severely Impaired von Willebrand Factor-Dependent Platelet Aggregation in Patients With a Continuous-Flow Left Ventricular Assist Device (HeartMate II). J Am Coll Cardiol. 2009;53(23):2162-2167.
25. Spanier T, Oz, M, Levin H, Weinberg A, Stamatis K, Stern D, Rose E, Schmidt, AM. Activation of Coagulation and Fibrinolytic Pathways in Patients With Left Ventricular Assist Devices. J Thorac Cardiovasc Surg. 1996;112(4):1090-1097. (Pubitemid 26339283)